Skip to main content
. 2013 Jun 13;2013:365830. doi: 10.1155/2013/365830

Table 1.

Summary of antithrombotic agents and comorbidities of patients treated with ESD under HR.

Patients (%)
Antithrombotic agents
 Warfarin 16 (67%)
 Aspirin 11 (46%)
 Ticlopidine 9 (38%)
 Clopidogrel 4 (17%)
 Cilostazol 1 (4%)
Comorbidity
 Atrial fibrillation 13 (54.1%)
 Ischemic heart disease 11 (45.8%)
 Valvular heart disease 5 (20.8%)
 Cerebral infarction 4 (16.7%)
 Pacemaker 2 (8.3%)
 Sick sinus syndrome 1 (4.2%)
 Deep vein thrombus 1 (4.2%)
 Pulmonary infarction 1 (4.2%)